161 related articles for article (PubMed ID: 26871287)
1. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.
Krause CJ; Popp O; Thirunarayanan N; Dittmar G; Lipp M; Müller G
Oncotarget; 2016 Mar; 7(9):10414-32. PubMed ID: 26871287
[TBL] [Abstract][Full Text] [Related]
2. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
3. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
[TBL] [Abstract][Full Text] [Related]
4. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
[TBL] [Abstract][Full Text] [Related]
6. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
[TBL] [Abstract][Full Text] [Related]
7. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice.
Thirunarayanan N; Cifire F; Fichtner I; Posner S; Benga J; Reiterer P; Kremmer E; Kölble K; Lipp M
Oncogene; 2007 Aug; 26(39):5702-12. PubMed ID: 17353903
[TBL] [Abstract][Full Text] [Related]
9. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
[TBL] [Abstract][Full Text] [Related]
10. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
Cannon M; Philpott NJ; Cesarman E
J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
12. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
13. Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation.
Feng H; Sun Z; Farzan MR; Feng P
J Virol; 2010 Apr; 84(7):3351-61. PubMed ID: 20106924
[TBL] [Abstract][Full Text] [Related]
14. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Cannon ML; Cesarman E
Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
16. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Raggo C; Ruhl R; McAllister S; Koon H; Dezube BJ; Früh K; Moses AV
Cancer Res; 2005 Jun; 65(12):5084-95. PubMed ID: 15958552
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
[TBL] [Abstract][Full Text] [Related]
18. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
19. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.
Burger M; Burger JA; Hoch RC; Oades Z; Takamori H; Schraufstatter IU
J Immunol; 1999 Aug; 163(4):2017-22. PubMed ID: 10438939
[TBL] [Abstract][Full Text] [Related]
20. Initiation of angiogenic Kaposi's sarcoma lesions.
Hayward GS
Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
